SABCS 2022 | San Antonio Breast Cancer Symposium 2022 highlights

Romualdo Barroso-Sousa, MD, PhD, Dasa Oncology, Sao Paolo, Brazil, talks on what to look out for at the San Antonio Breast Cancer Symposium (SABCS) 2022, including in new waves of hormonal therapy agents, data on antibody-drug conjugates (ADCs) for HER2-positive breast cancer and data on the POSITIVE (NCT02308085) trial on investigating pregnancy outcome and safety of interrupting therapy for women with endocrine responsive breast cancer. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.